U.S. flag

An official website of the United States government

HLA Laboratory (Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas), HLA-Lab

General information

HLA Laboratory, HLA-Lab
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Calzada de Tlalpan 4502, Col. Sección XVI, Delegación Tlalpan
Mexico
Distrito Federal
Mexico - 14080

Organization ID: 507267

Personnel

Assertion criteria

Level: Assertion criteria not provided

    Summary of submissions to ClinVar

    Total submissions: 118

    Gene

    GeneSubmissionsLast Updated
    ACE1Jan 7, 2023
    ADAM331Dec 21, 2022
    ADRB11Jul 5, 2022
    AGER4Oct 11, 2023
    ARNT22Jul 5, 2022
    ATP2B22Oct 19, 2023
    BMAL23Jul 5, 2022
    CHRNA51Dec 21, 2022
    CYP11A11Jul 5, 2022
    CYP19A11Jul 5, 2022
    CYP2C83Jul 5, 2022
    CYP2C92Jul 5, 2022
    CYP2J21Jul 5, 2022
    CYP2R12Jul 5, 2022
    CYP46A11Jul 5, 2022
    CYP4A221Jul 5, 2022
    CYP4B11Jul 5, 2022
    CYP4Z11Jul 5, 2022
    DOCK21Oct 19, 2023
    DSP3Jun 8, 2021
    F51Jul 8, 2021
    FAM13A6Jun 8, 2021
    GSTP11Jul 5, 2022
    HHIP6Jul 8, 2020
    HSPA1A4Nov 3, 2019
    HSPA1B2Nov 3, 2019
    HSPA1L1Nov 3, 2019
    IFNAR28Oct 19, 2023
    IFNAR2-IL10RB8Oct 19, 2023
    IL1B3Mar 30, 2020
    LOC1070636102Nov 3, 2019
    LOC1268058991Jul 5, 2022
    MGST14Jul 5, 2022
    MGST36Jul 5, 2022
    MIR4713HG1Jul 5, 2022
    MUC5B1Jun 13, 2022
    PADI24Jul 2, 2020
    PADI44Jul 2, 2020
    PIRC661Jul 5, 2022
    SCGB1A11Mar 16, 2021
    SERPINA12Feb 13, 2024
    SERPINE11Jul 8, 2021
    TERT3Jun 8, 2021
    TLR43Oct 19, 2023
    TMPRSS21Oct 19, 2023
    TNF4Aug 18, 2021
    TNFRSF1A6Oct 19, 2023
    TNFRSF1B6Oct 19, 2023
    TOLLIP5Jun 8, 2021

    Condition

    NameSubmissionsLast Updated
    Abnormal pulmonary interstitial morphology8Jul 2, 2020
    Antisynthetase syndrome3Mar 30, 2020
    Associated with severe COVID-19 disease11Oct 19, 2023
    COPD, severe early onset6Oct 19, 2023
    Chronic obstructive pulmonary disease21Jun 8, 2021
    Chronic obstructive pulmonary disease, biomass related3Jul 8, 2020
    Combined pulmonary fibrosis-emphysema syndrome4Jun 8, 2021
    Interstitial lung disease 25Jun 8, 2021
    Mortality risk in patients with severe coronavirus disease (COVID-19)5May 19, 2022
    Pulmonary disease, chronic obstructive, susceptibility to31Jul 5, 2022
    Rheumatoid arthritis8Jul 2, 2020
    Risk of requirement of invasive mechanical ventilation in patients with severe COVID-191Jan 7, 2023
    Susceptibility to coronavirus disease (COVID-19) severity and mortality due to low plasma levels of MUC5B1Jun 13, 2022
    Susceptibility to severe coronavirus disease (COVID-19)9Feb 13, 2024
    Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process2Jul 8, 2021
    Susceptibility to severe coronavirus disease (COVID-19) due to high levels of fibrinogen and C-reactive protein1Dec 21, 2022
    Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR21Aug 18, 2021
    Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR31Aug 18, 2021
    Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR41Aug 18, 2021
    Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR51Aug 18, 2021
    Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR61Aug 18, 2021
    Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR71Aug 18, 2021
    not specified1Dec 21, 2022